Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Diabetes, Obesity & Metabolism|January 30, 2009
Reverse cholesterol transport in type 2 diabetes mellitusK C B TanEuropean Journal of Clinical Investigation|March 29, 2003
Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitusK C B Tan, S W M Shiu, Y WongAtherosclerosis|March 10, 2005
Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitusK C B Tan, S W M Shiu, Y Wong, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 8, 2013
Possible FRAX-based intervention thresholds for a cohort of Chinese postmenopausal womenE Cheung, C-L Cheung, A W C Kung, et al.Clinical Endocrinology|November 18, 2003
Effects of treatment with Sandostatin LAR on small dense LDL and remnant-like lipoproteins in patients with acromegalyK C B Tan, R W C Pang, S C Tiu, et al.Clinical Obesity|April 1, 2015
A middle-aged man with increasing body fatJ K Y Lam, K S L Lam, W S Chow, et al.Diabetes/Metabolism Research and Reviews|January 4, 2006
Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitusK C B Tan, S W M Shiu, Y Wong, et al.Diabetologia|September 14, 2006
Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetesK C B Tan, S W M Shiu, W S Chow, et al.Atherosclerosis|September 8, 2009
Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetesH L Tam, S W M Shiu, Y Wong, et al.Diabetic Medicine : a Journal of the British Diabetic Association|February 26, 2013
Effect of insulin on the soluble receptor for advanced glycation end products (RAGE)J K Y Lam, Y Wang, S W M Shiu, et al.Pageof 3